CLEC7A and neoplasm: In pancreatic cancer, Dectin-1 was found to be able to reprogram the tumor-infiltrating macrophages into immune tolerogenic phenotypes and subsequently induce adaptive immunosuppression, which is dependent on the activation of the SYK signaling pathway (35).